ABSTRACT: The use of nebulized racemic epinephrine to improve ventilatory function in the newborn postextubation was studied. Forty-five infants intubated for more than 3 days were randomized to ...
In a recent study by Tanimoto and colleagues, neffy produced pharmacodynamic results that were comparable with or higher than autoinjectors and manual injection, including more efficient increases in ...
The designation is supported by data from Part 1 of the EPIPHAST study, which compared the pharmacokinetics and pharmacodynamics of AQST-109 to intramuscular epinephrine in healthy adults. The Food ...
The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...
The Food and Drug Administration, in a surprise move, has decided not to approve an epinephrine nasal spray that would have been the first needle-free alternative to epinephrine autoinjectors, ...
WASHINGTON -- Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of resolved allergic symptoms in children and ...
A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free ...
FDA advisors recommended that the agency approve an intranasal epinephrine product for type I allergic reactions, including anaphylaxis, despite concerns about the lack of clinical efficacy data. On ...
The Food and Drug Administration has declined to approve an alternative to epinephrine autoinjectors such as EpiPens, telling the maker of a nasal spray that more study is required. ARS Pharma, maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results